https://www.nextechinvest.com/news-articles/aumolertinib-significantly-prolongs-progression-free-survival-with-fewer-side-effects-in-the-first-line-treatment-of-patients-with-advanced-egfr-mutated-non-small-cell-lung-cancer/
Aumolertinib Significantly Prolongs Progression Free Survival with Fewer Side Effects in the...
progression free survivalside effectsin theaumolertinibsignificantly